Genetic testing may also identify patients with variants causing alpha-cell hypersecretion who could preferentially benefit from glucagon-lowering treatments
Common indications include: Pernicious anaemia an autoimmune condition where the stomach cannot produce intrinsic factor, a protein necessary for B12 absorption [8] [9] Malabsorption disorders including Crohn's disease, coeliac disease, or following gastric surgery Strict vegan or vegetarian diets with confirmed deficiency though high-dose oral B12 may be sufficient if no malabsorption exists Certain medications such as metformin or proton pump inhibitors that may interfere with B12 absorption [9] [10] Neurological symptoms including peripheral neuropathy, memory problems, or balance difficulties related to deficiency Diagnosis should be confirmed through blood tests measuring serum B12 levels, full blood count, folate, and often anti-intrinsic factor antibodies
The latter can be conceptualized by direct effects on tissue physiology, resetting of local clocks, and modulation of rhythms through interaction with tissue rhythm regulation
This results in tissue damage, high sputum viscosity, and impaired airway clearance
